Objective: The objective is to assess the relationship of Log (TG)/HDL-c as surrogate estimate of atherogenic dyslipidemia with urinary albumin excretion rate and cardiovascular risk among black patients with type 2 diabetes. Patients and methods: A post-hoc analysis of data from 181 type 2 diabetes patients enrolled in a cross-sectional study of urinary albumin excretion rate seen at a tertiary healthcare. Microalbuminuria and macroalbuminuria were defined as ACR 30 - 299.9 mg/g and ACR ≥ 300 mg/g, respectively. Quartiles of Log (TG)/HDL-c were used as surrogate estimates of atherogenic dyslipidemia. Cardiovascular risk was assessed using WHO chart for estimation of CV risk in low and middle income countries. Comparisons across Log (TG)/HDL-c quartiles were performed using one way ANOVA and Chi square for trend as appropriate. P < 0.05 defined the level of statistical significance. Results: A high prevalence (69%) of atherogenic dyslipidemia (AD) was observed in the present case series of Black Africans with type 2 diabetes. Average total cholesterol levels showed significant (p = 0.010) trends towards lower values across quartiles of Log (TG)/ HDL-c. No significant trends were observed for average UAER and cardiovascular risk across quartiles of Log (TG)/HDL-c. Conclusion: Log (TG)/HDL-c as a surrogate estimate of atherogenic failed to predict cardiovascular risk in the present case series of black patients with type 2 diabetes.
Hamilton, S.J. and Watts, G.F. (2013) Atherogenic Dyslipidemia and Combination Pharmacotherapy in Diabetes: Recent Trials. The Review of Diabetic Studies, 10, 191-203. http://dx.doi.org/10.1900/RDS.2013.10.191
Agouridis, A.P., Rizos, C.V., Elisaf, M.S. and Filippatos, T.D. (2013) Does Combination Therapy with Statins and Fibrates Prevent Cardiovascular Disease in Diabetic Patients with Atherogenic Mixed Dyslipidemia? The Review of Diabetic Studies, 10, 171-190. http://dx.doi.org/10.1900/RDS.2013.10.171
Pandeya, A., Sharma, M., Regmi, P., Basukala, A. and Lamsal, M.S. (2002) Pattern of Dyslipidemia and Evaluation of Non-HDL-c as a Marker of Risk Factor for Cardiovascular Disease in Type 2 Diabetes Mellitus. Nepal Med Coll J, 14, 278-282.
Charlton-Menys, V., Betteridge, D.J., Colhoun, H., Fuller, J., France, M., Hitman, G.A., et al. (2009) Target of Statin Therapy; LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CRDS). Clinical Chemistry, 55, 473-480. http://dx.doi.org/10.1373/clinchem.2008.111401
Wanner, C. and Krane, V. (2011) Recent Advances in the Treatment of Atherogenic Dyslipidemia in Type 2 Diabetes Mellitus. Kidney and Blood Pressure Research, 34, 209-217. http://dx.doi.org/10.1159/000326849
Ginsberg, H.N. and MacCallun, P.R. (2009) The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: II. Therapeutic Management of Atherogenic Dyslipidemia. Journal of Clinical Hypertension, 11, 520-527. http://dx.doi.org/10.1111/j.1559-4572.2009.00060.x
de Boer, I.H., Astor, H.K., Kramer, H., Palmas, W., Rudser, K., Seliger, S., et al. (2008) Mild Elevations in Urine Albumin Excretion Are Associated with Atherogenic Lipid Abnormalities in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis, 197, 407-414. http://dx.doi.org/10.1016/j.atherosclerosis.2007.06.018
Tennebaum, A. and Fisman, E.Z. (2012) Fibrates Are an Essential Part of Modern Anti-Dyslipidemic Arsenal: Spotlight on Atherogenic Dyslipidemia and Residual Risk Reduction. Cardiovascular Diabetology, 11, 125. http://dx.doi.org/10.1186/1475-2840-11-125
Hermans, P.H., Ahn, A.A. and Rousseau, M.F. (2012) The Atherogenic Dyslipidemia Ratio [Log(TG)/HDL-c] Is Associated with Residual Vascular Risk, Beta-Cell Function Loss and Microangiopathy in Type 2 Diabetes Females. Lipids in Health and Disease, 11, 132. http://dx.doi.org/10.1186/1476-511X-11-132
Hermans, M.P., Ahn, S.A. and Rousseau, M.F. (2010) [log(TG)/HDL-c] Is Related to Both Residual Cardiometabolic Risk and B-Cell Function Loss in Type 2 Diabetes Males. Cardiovascular Diabetology, 9, 88. http://dx.doi.org/10.1186/1475-2840-9-88
Onat, A., Can, G., Kaya, H. and Hergenc, G. (2010) Atherogenic Index of Plasma (Log10 Triglyceride/High-Density Lipoprotein-Cholesterol) Predicts High Blood Pressure, Diabetes, and Vascular Events. Journal of Clinical Lipidology, 4, 89-98. http://dx.doi.org/10.1016/j.jacl.2010.02.005
Jisieike-Onuigbo, N.N., Unuigbe, E.I., Kalu, O.A., Oguejiofor, C.O. and Onuigbo, P.C. (2011) Prevalence of Dyslipidemia among Adult Diabetic Patients with Overt Diabetic Nephropathy in Anambra State South-East Nigeria. Nigerian Journal of Clinical Practice, 14, 171-175. http://dx.doi.org/10.4103/1119-3077.84009
Risassi, J.R., Nseka, M.N., Mvitu, M., Muyer, M.T., Kimenyembo, W., Mandja, M., Bieleli, E.O., Mapatano, M.A., Lepira, F.B., Sumaili, E.K., Kaimbo, W.K., Nge, O., Buntinx, F. and Muls, E. (2010) Albuminuria during the Screening for Diabetes in a Semi Rural Area (Kisantu City, DR Congo). Nephrology & Therapeutics, 6, 513-519.
Bennett, P.H., Haffner, S., Kasiske, B.L., Keane, W.F., Mogensen, C.E., Parving, H.H., et al. (1995) Screening and Management of Microalbuminuria in Patients with Diabetes Mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. American Journal of Kidney Diseases, 25, 107-112. http://dx.doi.org/10.1016/0272-6386(95)90636-3
Friedelwald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clinical Chemistry, 18, 499-502.
Mendis, S., Puska, P. and Norrving, B. (Eds.) (2011) Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization in Collaboration with the World Heart Federation and the World Stroke Organization, Geneva.
Wang, S.H., Wang, L., Zhou, Y., Guo, Y.J., Yuan, Y., Li, F.F., et al. (2012) Prevalence and Control of Dyslipidaemia among Diabetic Patients with Microalbuminuria in a Chinese Hospital. Diabetes & Vascular Disease Research, 10, 169-178. http://dx.doi.org/10.1177/1479164112454756
Yu, S.S.K., Darleen, C., Castillo, D.C., Courville, A.B. and Sumner, A.E. (2012) The Triglyceride Paradox in People of African Descent. Metabolic Syndrome and Related Disorders, 10, 77-82. http://dx.doi.org/10.1089/met.2011.0108
Nwagha, U.I., Ikekpeazu, E.J., Ejezie, F.E., Neboh, E.E. and Maduka, I.C. (2010) Atherogenic Index of Plasma as Auseful Predictor of Cardiovascular Risk among Postmenopausal Women in Enugu, Nigeria. African Health Sciences, 10, 248-252.
Knight, M.G., Goedecke, J.H., Ricks, M., Evans, J., Levitt, N.S., Tulloch-Reid, M.K. and Sumner, A.E. (2011) The TG/HDL-C Ratio Does Not Predict Insulin Resistance in Overweight Women of African Descent: A Study of South African, African American and West African Women. Ethnicity & Disease, 21, 490-494.
Zoppini, G., Negri, C., Stoico, V., Casali, S., Pichiri, I. and Bonora, I. (2012) Triglyceride-High-Density Lipoprotein Is Associated with Microvascular Complications in Type 2 Diabetes Mellitus. Metabolism—Clinical and Experimental, 61, 22-29. http://dx.doi.org/10.1016/j.metabol.2011.05.004
Sumner, A.E., Finley, K.B., Genovese, D.J., Criqui, M.H. and Boston, R.C. (2005) Fasting Triglyceride and the Triglyceride-HDL Cholesterol Ratio Are Not Markers of Insulin Resistance in African Americans. Archives of Internal Medicine, 165, 1395-1400. http://dx.doi.org/10.1001/archinte.165.12.1395
Sumner, A.E., Harman, J.L., Buxbaum, S.G., Miller, B.V., Tambay, A.V., Wyatt, S.B., et al. (2010) The Triglyceride/High-Density Lipoprotein Cholesterol Ratio Fails to Predict Insulin Resistance in African-American Women: An Analysis of Jackson Heart Study. Metabolic Syndrome and Related Disorders, 8, 511-514. http://dx.doi.org/10.1089/met.2010.0028
Goedecke, J.H., Utzschneider, K., Faulenbach, M.V., et al. (2010) Ethnic Differences in Serum Lipoproteins and Their Determinants in South African Women. Metabolism—Clinical and Experimental, 59, 1341-1350. http://dx.doi.org/10.1016/j.metabol.2009.12.018
Kim-Dorner, S.J., Deuster, P.A., Zeno, S.A., Remaley, A.T. and Poth, M. (2010) Should Triglycerides and the Triglycerides to High-Density Lipoprotein Cholesterol Ratio Be Used as Surrogates for Insulin Resistance? Metabolism— Clinical and Experimental, 59, 299-304. http://dx.doi.org/10.1016/j.metabol.2009.07.027